Clinical Trial Update: LIraglutide and Beta-cell RepAir (LIBRA) Study [Phase 3]

View source ↗

Summary

Phase 3 LIBRA trial evaluating liraglutide for Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED